Diffuse large cell lymphoma - PubMed (original) (raw)
Review
Diffuse large cell lymphoma
B Coiffier. Curr Opin Oncol. 2001 Sep.
Abstract
A review of new or emerging ideas concerning diffuse large B-cell lymphomas is presented, with particular emphasis on histologic classification, genetic prognostic factors, first-line and salvage treatments, and specific locations such as neurologic, cutaneous, or gastrointestinal sites. This lymphoma remains the most heterogeneous of all lymphomas for its clinical characteristics and outcome. This heterogeneity is probably secondary to the fact that a large proportion of lymphomas seems to occur from a transformation of an unknown indolent lymphoma.
Similar articles
- Treatment of diffuse large B-cell lymphoma.
Coiffier B. Coiffier B. Curr Hematol Rep. 2005 Jan;4(1):7-14. Curr Hematol Rep. 2005. PMID: 15610654 Review. - The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Thieblemont C, Briere J, Mounier N, Voelker HU, Cuccuini W, Hirchaud E, Rosenwald A, Jack A, Sundstrom C, Cogliatti S, Trougouboff P, Boudova L, Ysebaert L, Soulier J, Chevalier C, Bron D, Schmitz N, Gaulard P, Houlgatte R, Gisselbrecht C. Thieblemont C, et al. J Clin Oncol. 2011 Nov 1;29(31):4079-87. doi: 10.1200/JCO.2011.35.4423. Epub 2011 Sep 26. J Clin Oncol. 2011. PMID: 21947824 - LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Peng W, Wu J, Feng J. Peng W, et al. Clin Exp Med. 2017 Feb;17(1):1-8. doi: 10.1007/s10238-015-0396-8. Epub 2015 Oct 16. Clin Exp Med. 2017. PMID: 26475621 - Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H, Berger F, Felman P, Callet-Bauchu E, Bryon PA, Traverse-Glehen A, Thieblemont C, Baseggio L, Michallet AS, Coiffier B, Salles G. Ghesquières H, et al. J Clin Oncol. 2006 Nov 20;24(33):5234-41. doi: 10.1200/JCO.2006.07.5671. Epub 2006 Oct 16. J Clin Oncol. 2006. PMID: 17043351 - Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature.
de Jonge AV, Roosma TJ, Houtenbos I, Vasmel WL, van de Hem K, de Boer JP, van Maanen T, Lindauer-van der Werf G, Beeker A, Timmers GJ, Schaar CG, Soesan M, Poddighe PJ, de Jong D, Chamuleau ME. de Jonge AV, et al. Eur J Cancer. 2016 Mar;55:140-6. doi: 10.1016/j.ejca.2015.12.001. Epub 2016 Jan 25. Eur J Cancer. 2016. PMID: 26820684 Review.
Cited by
- Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma.
Berker N, Yeğen G, Özlük Y, Doğan Ö. Berker N, et al. Turk J Haematol. 2023 Aug 31;40(3):162-173. doi: 10.4274/tjh.galenos.2023.2023.0110. Epub 2023 Jul 31. Turk J Haematol. 2023. PMID: 37519110 Free PMC article. - Circulating Tumor DNA Profiling of a Diffuse Large B Cell Lymphoma Patient with Secondary Acute Myeloid Leukemia.
Kerle IA, Jägerhuber L, Secci R, Pfarr N, Blüm P, Roesch R, Götze KS, Weichert W, Bassermann F, Ruland J, Winter C. Kerle IA, et al. Cancers (Basel). 2022 Mar 8;14(6):1371. doi: 10.3390/cancers14061371. Cancers (Basel). 2022. PMID: 35326522 Free PMC article. - Diffuse large B-cell lymphoma presenting as reversible intrapulmonary arteriovenous shunts with hypoxia, fever and progressive jaundice: a case report and literature review.
Hou H, Guo C, Que C, Nie L, Zhang Q, Zhao H, Nong L, Ma W, Wang Q, Liang Z, Wang B, Ma J, Wang G. Hou H, et al. BMC Pulm Med. 2022 Mar 15;22(1):89. doi: 10.1186/s12890-022-01881-8. BMC Pulm Med. 2022. PMID: 35292006 Free PMC article. Review. - High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.
Marino D, Pizzi M, Kotova I, Schmidt R, Schröder C, Guzzardo V, Talli I, Peroni E, Finotto S, Scapinello G, Dei Tos AP, Piazza F, Trentin L, Zagonel V, Piovan E. Marino D, et al. Cancers (Basel). 2022 Jan 11;14(2):338. doi: 10.3390/cancers14020338. Cancers (Basel). 2022. PMID: 35053500 Free PMC article. - Profiling of ribose methylations in ribosomal RNA from diffuse large B-cell lymphoma patients for evaluation of ribosomes as drug targets.
Krogh N, Asmar F, Côme C, Munch-Petersen HF, Grønbæk K, Nielsen H. Krogh N, et al. NAR Cancer. 2020 Dec 22;2(4):zcaa035. doi: 10.1093/narcan/zcaa035. eCollection 2020 Dec. NAR Cancer. 2020. PMID: 34316692 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources